AXSM vs. NVO
Compare and contrast key facts about Axsome Therapeutics, Inc. (AXSM) and Novo Nordisk A/S (NVO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: AXSM or NVO.
Performance
AXSM vs. NVO - Performance Comparison
Returns By Period
In the year-to-date period, AXSM achieves a 23.37% return, which is significantly higher than NVO's 0.30% return.
AXSM
23.37%
6.27%
32.37%
63.38%
23.97%
N/A
NVO
0.30%
-11.88%
-24.01%
0.48%
32.57%
18.92%
Fundamentals
| AXSM | NVO | |
|---|---|---|
| Market Cap | $4.76B | $472.80B |
| EPS | -$6.58 | $2.99 |
| PEG Ratio | 0.00 | 1.53 |
| Total Revenue (TTM) | $338.46M | $270.58B |
| Gross Profit (TTM) | $306.46M | $229.07B |
| EBITDA (TTM) | -$300.59M | $135.97B |
Key characteristics
| AXSM | NVO | |
|---|---|---|
| Sharpe Ratio | 1.55 | 0.03 |
| Sortino Ratio | 2.18 | 0.27 |
| Omega Ratio | 1.27 | 1.03 |
| Calmar Ratio | 1.52 | 0.03 |
| Martin Ratio | 4.22 | 0.09 |
| Ulcer Index | 15.62% | 10.91% |
| Daily Std Dev | 42.55% | 30.41% |
| Max Drawdown | -86.65% | -71.30% |
| Current Drawdown | -7.58% | -29.88% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between AXSM and NVO is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
AXSM vs. NVO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Axsome Therapeutics, Inc. (AXSM) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
AXSM vs. NVO - Dividend Comparison
AXSM has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 1.41%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AXSM Axsome Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 1.41% | 1.00% | 1.20% | 1.34% | 1.86% | 2.14% | 2.47% | 2.12% | 3.93% | 1.31% | 1.96% | 1.72% |
Drawdowns
AXSM vs. NVO - Drawdown Comparison
The maximum AXSM drawdown since its inception was -86.65%, which is greater than NVO's maximum drawdown of -71.30%. Use the drawdown chart below to compare losses from any high point for AXSM and NVO. For additional features, visit the drawdowns tool.
Volatility
AXSM vs. NVO - Volatility Comparison
Axsome Therapeutics, Inc. (AXSM) has a higher volatility of 12.86% compared to Novo Nordisk A/S (NVO) at 8.75%. This indicates that AXSM's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
AXSM vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Axsome Therapeutics, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities